Valuation : Sanofi

Market Cap 92.55B 107B 86.76B 79.21B 149B 10,225B 150B 1,029B 402B 5,171B 402B 394B 17,144B P/E 2026 *
12.3x
P/E 2027 * 10.7x
Enterprise Value 104B 120B 97.5B 89.02B 167B 11,491B 168B 1,156B 451B 5,811B 452B 442B 19,267B EV / Sales 2026 *
2.19x
EV / Sales 2027 * 1.99x
Free-Float
88.34%
Yield 2026 *
5.51%
Yield 2027 * 5.82%
1 day-0.03%
1 week-2.08%
Current month+4.26%
1 month-3.20%
3 months+3.09%
6 months-5.91%
Current year-6.89%
1 week 76.9
Extreme 76.9
79.18
1 month 73.56
Extreme 73.56
79.18
Current year 71.27
Extreme 71.27
84.9
1 year 71.27
Extreme 71.27
90.78
3 years 71.27
Extreme 71.27
111
5 years 71.27
Extreme 71.27
111
10 years 63.15
Extreme 63.15
111
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer 51 11/09/2023
Director TitleAgeSince
Director/Board Member 60 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 65 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-2.08% - - 107B
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.68%-2.68%+28.46%+48.12% 406.59B
Weighted average by Cap. -0.45%-3.46%+38.16%+65.11%

Financials

2026 *2027 *
Net sales 47.59B 55.13B 44.61B 40.73B 76.63B 5,258B 76.96B 529B 206B 2,659B 207B 202B 8,816B 50.7B 58.72B 47.52B 43.39B 81.63B 5,601B 81.98B 563B 220B 2,832B 220B 216B 9,391B
Net income 7.91B 9.16B 7.42B 6.77B 12.74B 874B 12.79B 87.92B 34.32B 442B 34.39B 33.65B 1,465B 9.24B 10.71B 8.67B 7.91B 14.88B 1,021B 14.95B 103B 40.11B 516B 40.19B 39.32B 1,712B
Net Debt 11.46B 13.27B 10.74B 9.81B 18.45B 1,266B 18.53B 127B 49.71B 640B 49.81B 48.73B 2,122B 8.3B 9.62B 7.78B 7.11B 13.37B 917B 13.43B 92.29B 36.03B 464B 36.1B 35.32B 1,538B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
28/08/26 €77.32 -0.03% 758
27/08/26 €77.34 -1.20% 1,491
26/08/26 €78.28 -0.63% 1,096
25/08/26 €78.78 +0.60% 1,770
24/08/26 €78.31 -0.82% 1,195
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
77.25EUR
Average target price
94.28EUR
Spread / Average Target
+22.04%

Quarterly revenue - Rate of surprise